Biotech

Agennix Announces Data From Talactoferrin Phase II Trial in Non-Small Cell Lung Cancer Published in Journal of Clinical Oncology

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: ...

Dynavax Reports Positive Immunogenicity Data From an Analysis of Hypo-Responsive Populations in HEPLISAV(TM) Phase 3 Trial

BERKELEY, CA: ...

Poniard Pharmaceuticals Announces Effectiveness of Form S-4 Registration Statement for the Proposed Merger with ALLOZYNE

SAN FRANCISCO, CA: ...

Advitech and Natunola Announce Completion of Merger, Private Placement and Change of Name to Botaneco

QUEBEC CITY, QUEBEC and WINCHESTER, ONTARIO: ...

Io Therapeutics, Inc. Announces Initiation of Dosing in a Phase II Clinical Trial of IRX4204 in Patients With Advanced Prostate Cancer

SANTA ANA, CA: ...

MethylGene Appoints Joseph Walewicz as Vice President, Business and Corporate Development

MONTREAL, CANADA: ...

Peregrine Completes Patient Enrollment in Second-Line Non-Small Cell Lung Cancer Trial; Data to Be Unblinded in First Half 2012

TUSTIN, CA: Third Randomized Phase II Trial Enrolled in Last 30 Days Sets Timeline for Multiple Upcoming Clinical Data Points in 2011 and 2012 ...

Critical Outcome Technologies Inc. Announces COTI-2 Scientific Results Accepted for Presentation at Influential Scientific Conference

LONDON, ONTARIO: ...

Tech Council of Maryland/MdBio Pursues Legislative Agenda to Encourage Investment and Foster Positive Regulatory Environment for Biotech Innovation

ROCKVILLE, MD: Announces Support for Proposals Developed by Biotechnology Industry Organization ...

SciClone Pharmaceuticals Announces Share Repurchase Program and Reaffirms 2011 Guidance

FOSTER CITY, CA: ...